Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03631290 · ClinicalTrials.gov registry record
Deprescribing for Older Dialysis Patients
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 48
- Enrollment target
NCT03631290: Completed study, sponsored by Duke University.
NCT03631290 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03631290 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
Aim 1 of the study is to identify the elements of a deprescribing intervention that address contextual factors specific to dialysis. Aim 2 of the study, described in this record, is to determine the feasibility of a deprescribing intervention tailored for older dialysis patients. Older adults receiving dialysis are often prescribed multiple medications. Some of these medications are used to treat symptoms, but they also can increase the chance of significant health problems. The purpose of this study is to identify if it is feasible to reduce the use of medications that have been identified as causing an increased risk for health problems.
Primary Outcome
Deprescribing events will be assessed for the Provider Only and Provider/Patient communication approaches. While this data is categorized into the two approaches, it is not intended for comparison.
Interventions
- BEHAVIORAL Deprescribing Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2023-12-13 |
What the finished NCT03631290 record still lists
NCT03631290 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Deprescribing Intervention is the first listed.
NCT03631290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03631290 about?
NCT03631290 is a clinical study titled "Deprescribing for Older Dialysis Patients". Aim 1 of the study is to identify the elements of a deprescribing intervention that address contextual factors specific to dialysis. Aim 2 of the study, described in this record, is to determine the feasibility of a deprescribing intervention tailored for older dialysis patients. Older adults rece...
What is the current status of trial NCT03631290?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2022-03-09. Estimated completion is 2023-12-13.
What interventions are being tested in trial NCT03631290?
The interventions under investigation include: Deprescribing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03631290?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI